Multicancer Detection Using Whole-Body MRI in a Preventive Health Population: A Retrospective Observational Study of 1,011 Individuals

Background: Single-cancer screening (SCS) reduces mortality for select cancers but overlooks many malignancies that contribute to overall cancer deaths. Screening whole-body MRI (sWB-MRI) is an emerging modality for multi-cancer detection (MCD) with potential in preventive care. We assessed the diagnostic yield and clinical implications of sWB-MRI in a preventive health population. Methods: In this retrospective single-center study, we evaluated 1,011 individuals without known active cancer who underwent noncontrast, multiparametric sWB-MRI (1.5 T with diffusion-weighted imaging) from January to December 2022. Of 2,632 individuals scanned, 1,044 (39.7%) completed routine clinical follow-up telephone calls approximately 12-16 months later; 33 with known active cancer were excluded. Imaging spanned head-to-ankle anatomy for the vast majority of studies, with structured reports available for primary care physician review. The primary outcome was the observed cancer detection percentage (CDP), based on patient-reported histopathological diagnoses of malignancy following evaluation or management of findings initially identified on sWB-MRI, along with the distribution of cancer types relative to established screening categories. Results: The cohort consisted of 52% males, with a mean age of 56.4 ± 12.9 years. Tissue sampling was reported in 4.9% (n = 50), with diagnostic-intent tissue sampling (dTS) in 4.1% (n = 41). The overall cancer detection percentage (O-CDP) was 2.18% (95% CI: 1.37%-3.28%), with 3.0% observed among those aged 65-79 years. Of 22 detected cancers, 15 (68.2%) belonged to cancer types outside the five predefined SCS categories, and one (4.5%) was of unknown primary origin. Fourteen cancers (63.6%) were retrospectively estimated to have localized disease. Two additional interval breast cancer diagnoses (0.2%) were reported during follow-up but were not identified in the original sWB-MRI reports. Clinically significant noncancer findings (e.g., aneurysms, meningiomas, hepatosteatosis) were associated with reported subsequent clinical interventions or monitoring. Conclusions: In this population, sWB-MRI enabled broad detection of some cancers not typically identified by SCS. The findings highlight the need to explore MCD imaging in larger, risk-stratified cohorts to inform screening policy, address missed cancer burdens, and enhance early detection strategies in population health. Prospective studies with standardized reporting frameworks (ONCO-RADS) and long-term outcomes are needed to support broader clinical integration.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2026-11-18
DOI
https://doi.org/10.7759/cureus.119908
Primary Topic
MRI in cancer diagnosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Multicancer Detection Using Whole-Body MRI in a Preventive Health Population: A Retrospective Observational Study of 1,011 Individuals

Jeffrey Michael Venstrom, Alex Exuzides, Candace Westgate, Madhurima Datta et al.
5 links
Cureus
MRI in cancer diagnosis
article

Multicancer Detection Using Whole-Body MRI in a Preventive Health Population: A Retrospective Observational Study of 1,011 Individuals

Jeffrey Michael Venstrom, Alex Exuzides, Candace Westgate, Madhurima Datta, Rebecca Nayeri, Daniel J. Durand, Pratik Shingru, Sam Hashemi, Yosef G. Chodakiewitz, Saqib Basar
article en

Abstract

Background: Single-cancer screening (SCS) reduces mortality for select cancers but overlooks many malignancies that contribute to overall cancer deaths. Screening whole-body MRI (sWB-MRI) is an emerging modality for multi-cancer detection (MCD) with potential in preventive care. We assessed the diagnostic yield and clinical implications of sWB-MRI in a preventive health population. Methods: In this retrospective single-center study, we evaluated 1,011 individuals without known active cancer who underwent noncontrast, multiparametric sWB-MRI (1.5 T with diffusion-weighted imaging) from January to December 2022. Of 2,632 individuals scanned, 1,044 (39.7%) completed routine clinical follow-up telephone calls approximately 12-16 months later; 33 with known active cancer were excluded. Imaging spanned head-to-ankle anatomy for the vast majority of studies, with structured reports available for primary care physician review. The primary outcome was the observed cancer detection percentage (CDP), based on patient-reported histopathological diagnoses of malignancy following evaluation or management of findings initially identified on sWB-MRI, along with the distribution of cancer types relative to established screening categories. Results: The cohort consisted of 52% males, with a mean age of 56.4 ± 12.9 years. Tissue sampling was reported in 4.9% (n = 50), with diagnostic-intent tissue sampling (dTS) in 4.1% (n = 41). The overall cancer detection percentage (O-CDP) was 2.18% (95% CI: 1.37%-3.28%), with 3.0% observed among those aged 65-79 years. Of 22 detected cancers, 15 (68.2%) belonged to cancer types outside the five predefined SCS categories, and one (4.5%) was of unknown primary origin. Fourteen cancers (63.6%) were retrospectively estimated to have localized disease. Two additional interval breast cancer diagnoses (0.2%) were reported during follow-up but were not identified in the original sWB-MRI reports. Clinically significant noncancer findings (e.g., aneurysms, meningiomas, hepatosteatosis) were associated with reported subsequent clinical interventions or monitoring. Conclusions: In this population, sWB-MRI enabled broad detection of some cancers not typically identified by SCS. The findings highlight the need to explore MCD imaging in larger, risk-stratified cohorts to inform screening policy, address missed cancer burdens, and enhance early detection strategies in population health. Prospective studies with standardized reporting frameworks (ONCO-RADS) and long-term outcomes are needed to support broader clinical integration.

Cureus
Community Health Network (US), St. Helena Hospital (US), VA Greater Los Angeles Healthcare System (US)
Good health and well-being
MRI in cancer diagnosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon